Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catrin Pritchard

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
Disease Models & Mechanisms|February 15, 2019
Early detection of pre-malignant lesions in a KRAS<sup>G12D</sup>-driven mouse lung cancer model by monitoring circulating free DNACallum P Rakhit, Ricky M Trigg, John Le Quesne, et al.
JNCI Cancer Spectrum|March 20, 2020
Reduced Protumorigenic Tumor-Associated Macrophages With Statin Use in Premalignant Human Lung AdenocarcinomaEsraa Al Dujaily, Juvenal Baena, Madhumita Das, et al.
Gynecologic Oncology|December 14, 2020
Development of a patient-derived explant model for prediction of drug responses in endometrial cancerAnna Collins, Gareth J Miles, Ian R Powley, et al.
Disease Models & Mechanisms|November 15, 2021
Statins mediate anti- and pro-tumourigenic functions by remodelling the tumour microenvironmentTamihiro Kamata, Esraa Al Dujaily, Salwa Alhamad, et al.
Cancer Cell|April 7, 2009
Oncogenic Braf induces melanocyte senescence and melanoma in miceNathalie Dhomen, Jorge S Reis-Filho, Silvy da Rocha Dias, et al.
British Journal of Cancer|January 3, 2020
Patient-derived explants (PDEs) as a powerful preclinical platform for anti-cancer drug and biomarker discoveryIan R Powley, Meeta Patel, Gareth Miles, et al.
Cancer Research|February 17, 2017
<i>Ex Vivo</i> Explant Cultures of Non-Small Cell Lung Carcinoma Enable Evaluation of Primary Tumor Responses to Anticancer TherapyEllie Karekla, Wen-Jing Liao, Barry Sharp, et al.
Mutagenesis|November 25, 2022
Ex vivo explant model of adenoma and colorectal cancer to explore mechanisms of action and patient response to cancer prevention therapiesSam Khan, Gareth J Miles, Constantinos Demetriou, et al.
Journal of Visualized Experiments : Jove|February 22, 2021
Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in PatientsGiuditta Viticchié, Ian Powley, Constantinos Demetriou, et al.
Iscience|February 15, 2020
DNMT3B Oncogenic Activity in Human Intestinal Cancer Is Not Linked to CIMP or BRAFV600E MutationDouglas J MacKenzie, Neil A Robertson, Iqbal Rather, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Disease Models & Mechanisms|February 15, 2019
Early detection of pre-malignant lesions in a KRAS<sup>G12D</sup>-driven mouse lung cancer model by monitoring circulating free DNACallum P Rakhit, Ricky M Trigg, John Le Quesne, et al.
JNCI Cancer Spectrum|March 20, 2020
Reduced Protumorigenic Tumor-Associated Macrophages With Statin Use in Premalignant Human Lung AdenocarcinomaEsraa Al Dujaily, Juvenal Baena, Madhumita Das, et al.
Gynecologic Oncology|December 14, 2020
Development of a patient-derived explant model for prediction of drug responses in endometrial cancerAnna Collins, Gareth J Miles, Ian R Powley, et al.
Disease Models & Mechanisms|November 15, 2021
Statins mediate anti- and pro-tumourigenic functions by remodelling the tumour microenvironmentTamihiro Kamata, Esraa Al Dujaily, Salwa Alhamad, et al.
Cancer Cell|April 7, 2009
Oncogenic Braf induces melanocyte senescence and melanoma in miceNathalie Dhomen, Jorge S Reis-Filho, Silvy da Rocha Dias, et al.
British Journal of Cancer|January 3, 2020
Patient-derived explants (PDEs) as a powerful preclinical platform for anti-cancer drug and biomarker discoveryIan R Powley, Meeta Patel, Gareth Miles, et al.
Cancer Research|February 17, 2017
<i>Ex Vivo</i> Explant Cultures of Non-Small Cell Lung Carcinoma Enable Evaluation of Primary Tumor Responses to Anticancer TherapyEllie Karekla, Wen-Jing Liao, Barry Sharp, et al.
Mutagenesis|November 25, 2022
Ex vivo explant model of adenoma and colorectal cancer to explore mechanisms of action and patient response to cancer prevention therapiesSam Khan, Gareth J Miles, Constantinos Demetriou, et al.
Journal of Visualized Experiments : Jove|February 22, 2021
Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in PatientsGiuditta Viticchié, Ian Powley, Constantinos Demetriou, et al.
Iscience|February 15, 2020
DNMT3B Oncogenic Activity in Human Intestinal Cancer Is Not Linked to CIMP or BRAFV600E MutationDouglas J MacKenzie, Neil A Robertson, Iqbal Rather, et al.
Pageof 6